.
  • NIFTY 25,424.65 -288.35 (-1.12%)
  • SENSEX 82,225.92 -1,068.74 (-1.28%)
 
BSE
NSE

Tuesday, February 24, 2026 , BSE Sensex : 82,225.92 82,225.92(-1.28%) , Adani Ports : 1,555.25 1,555.25(-0.08%) , Asian Paints : 2,413.25 2,413.25(-0.64%) , Axis Bank : 1,387.65 1,387.65(0.08%) , Bajaj Finance : 1,023.80 1,023.80(-0.70%) , Bajaj Finserv : 2,046.05 2,046.05(-0.24%) , Bharat Electron : 435.00 435.00(-1.07%) , Bharti Airtel : 1,940.70 1,940.70(-2.83%) , Eternal : 253.95 253.95(-5.28%) , HCL Technologies : 1,339.40 1,339.40(-6.10%) , HDFC Bank : 910.70 910.70(-1.42%) , Hind. Unilever : 2,359.30 2,359.30(0.62%) , ICICI Bank : 1,384.80 1,384.80(-1.02%) , Infosys : 1,276.55 1,276.55(-3.91%) , Interglobe Aviat : 4,850.20 4,850.20(-0.23%) , ITC : 323.55 323.55(-0.55%) , Kotak Mah. Bank : 427.60 427.60(-0.72%) , Larsen & Toubro : 4,258.50 4,258.50(-3.59%) , M & M : 3,429.90 3,429.90(-0.44%) , Maruti Suzuki : 14,924.40 14,924.40(-0.95%) , NTPC : 382.75 382.75(1.94%) , Power Grid Corpn : 304.85 304.85(0.49%) , Reliance Industries : 1,430.15 1,430.15(0.16%) , SBI : 1,223.85 1,223.85(-0.32%) , Sun Pharma.Inds. : 1,730.55 1,730.55(-0.10%) , Tata Steel : 209.15 209.15(0.53%) , TCS : 2,574.50 2,574.50(-3.79%) , Tech Mahindra : 1,346.55 1,346.55(-6.60%) , Titan Company : 4,294.20 4,294.20(0.51%) , Trent : 3,934.65 3,934.65(-2.93%) , UltraTech Cem. : 12,951.50 12,951.50(-0.18%) ,

Nifty 50 : 25,424.65 -288.35(-1.12%) , Adani Enterp. : 2,183.00 -8.00(-0.37%) , Adani Ports : 1,555.40 -0.40(-0.03%) , Apollo Hospitals : 7,720.50 27.50(0.36%) , Asian Paints : 2,413.10 -16.60(-0.68%) , Axis Bank : 1,387.60 0.90(0.06%) , Bajaj Auto : 9,829.00 -76.50(-0.77%) , Bajaj Finance : 1,023.55 -7.45(-0.72%) , Bajaj Finserv : 2,043.30 -8.30(-0.40%) , Bharat Electron : 435.05 -4.70(-1.07%) , Bharti Airtel : 1,941.00 -56.30(-2.82%) , Cipla : 1,326.70 0.20(0.02%) , Coal India : 430.95 4.95(1.16%) , Dr Reddy's Labs : 1,300.20 -7.20(-0.55%) , Eicher Motors : 7,929.00 -109.50(-1.36%) , Eternal : 254.00 -14.00(-5.22%) , Grasim Inds : 2,879.30 5.90(0.21%) , HCL Technologies : 1,339.20 -87.00(-6.10%) , HDFC Bank : 910.50 -13.10(-1.42%) , HDFC Life Insur. : 734.75 -7.70(-1.04%) , Hind. Unilever : 2,358.60 13.20(0.56%) , Hindalco Inds. : 922.85 6.65(0.73%) , ICICI Bank : 1,384.80 -14.60(-1.04%) , Infosys : 1,275.50 -52.00(-3.92%) , Interglobe Aviat : 4,850.30 -11.90(-0.24%) , ITC : 323.50 -1.90(-0.58%) , Jio Financial : 255.25 -2.55(-0.99%) , JSW Steel : 1,254.50 14.00(1.13%) , Kotak Mah. Bank : 427.70 -3.00(-0.70%) , Larsen & Toubro : 4,259.20 -158.90(-3.60%) , M & M : 3,433.20 -13.90(-0.40%) , Maruti Suzuki : 14,926.00 -146.00(-0.97%) , Max Healthcare : 1,086.40 2.80(0.26%) , Nestle India : 1,320.00 4.90(0.37%) , NTPC : 382.75 7.30(1.94%) , O N G C : 276.50 0.85(0.31%) , Power Grid Corpn : 304.80 1.45(0.48%) , Reliance Industries : 1,428.80 0.80(0.06%) , SBI : 1,223.30 -4.50(-0.37%) , SBI Life Insuran : 2,082.90 -26.70(-1.27%) , Shriram Finance : 1,061.70 -3.00(-0.28%) , Sun Pharma.Inds. : 1,731.80 -0.50(-0.03%) , Tata Consumer : 1,178.00 6.20(0.53%) , Tata Motors PVeh : 377.55 -2.40(-0.63%) , Tata Steel : 209.13 0.99(0.48%) , TCS : 2,573.70 -102.60(-3.83%) , Tech Mahindra : 1,345.40 -95.50(-6.63%) , Titan Company : 4,294.50 21.80(0.51%) , Trent : 3,931.30 -123.60(-3.05%) , UltraTech Cem. : 12,960.00 -16.00(-0.12%) , Wipro : 200.14 -5.75(-2.79%) , Tuesday, February 24, 2026

Home >> Markets >> Equities >> News - News Details
DAILY MARKET TRACKER
MARKET ANALYSIS
NEWS
CORPORATE INFO
CORPORATE ACTIONS
OTHER MARKETS
Hot Pursuit
24-Feb-2026     14:46
Indoco Remedies rises on USFDA approval for Brivaracetam oral solution

The approval allows the company to market a generic version of Briviact 10 mg/mL oral solution, the reference listed drug (RLD) of UCB, Inc.

The company said its Brivaracetam Oral Solution has been determined to be bioequivalent and therapeutically equivalent to the RLD.

The product will be manufactured at Indoco Remedies' facility located at L-14, Verna Industrial Area, Verna, Goa ' 403722, India.

Brivaracetam Oral Solution (10 mg/mL) is a prescription antiepileptic drug indicated for the treatment of partial-onset seizures in patients aged one month and older.

Aditi Panandikar, managing director (MD) said, 'The ANDA approval for Brivaracetam is a significant milestone for us as we continue to strengthen our presence in the Regulated Markets. We are committed to offering innovative and affordable healthcare to patients worldwide.'

Indoco Remedies is engaged in the manufacturing and marketing of Formulations and Active Pharmaceutical Ingredients. The Company caters to both Domestic and International markets.

The company's consolidated net loss of Rs 23.64 crore in Q3 FY26 as against net loss of Rs 27.30 crore in Q3 FY25. Revenue from operations rose 7.9% year on year to Rs 434.34 crore in Q3 FY26.

Powered by Capital Market - Live News